Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898456 · ClinicalTrials.gov registry record
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
A clinical trial of Leukemia, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT00898456 is a study of Leukemia that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 600 participants, above the 484-participant average among 233 other Leukemia trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00898456, a study of Leukemia, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial studies multidrug resistance genes in patients with acute myeloid leukemia. Studying samples of bone marrow or blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer. It may also help doctors learn more about drug resistance and how patients respond to treatment.
Conditions Studied
Interventions
- GENETIC gene expression analysis
- GENETIC protein expression analysis
- GENETIC molecular genetic technique
- GENETIC polymorphism analysis
- OTHER diagnostic laboratory biomarker analysis
Study Locations (1)
Indiana
- Fort Wayne Medical Oncology and Hematology - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2006-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898456
The ClinicalTrials.gov registry entry for NCT00898456 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 484-participant average among 233 other Leukemia trials with a reported enrollment target (24% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Leukemia appearing as the primary indexed condition, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00898456 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00898456 about?
NCT00898456 is a clinical study titled "Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia". This research trial studies multidrug resistance genes in patients with acute myeloid leukemia. Studying samples of bone marrow or blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in deoxyribonucleic acid (DNA) and identify biomarkers related...
What is the current status of trial NCT00898456?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2006-10.
What conditions does trial NCT00898456 study?
This clinical trial studies the following conditions: Leukemia.
What interventions are being tested in trial NCT00898456?
The interventions under investigation include: gene expression analysis (GENETIC), protein expression analysis (GENETIC), molecular genetic technique (GENETIC), polymorphism analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00898456?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00898456 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.